Back to all announcements

DJ DXS International plc Director/Pdmr Shareholding

 
TIDMDXSP 
 
 
   DXS INTERNATIONAL PLC 
 
   Director Dealing 
 
   The Board of DXS International plc (the "Company"), the NEX quoted 
clinical decision support developer and supplier of clinical decision 
support systems is pleased to confirm that it has been notified that the 
Chief Executive, David Immelman, has purchased 20,002 Ordinary Shares at 
a price of 9.9p per share on 30 November 2018. 
 
   Following the transaction specified above Mr Immelman holds 3,677,541 
Ordinary Shares representing 10.45% of the issued share capital of the 
Company. 
 
   The Directors of DXS International plc accept responsibility for this 
announcement 
 
   Enquiries: 
 
 
 
 
David Immelman (Chief      01252 719800 
 Executive)                 david@dxs-systems.com 
 DXS International plc 
Wrecclesham House 
 Wrecclesham Road 
 Farnham 
 Surrey 
 GU10 4PS 
www.dxs-systems.co.uk 
 
 
 
 
 
 
David Papworth            0207 101 7676 
 City & Merchant           info@cityandmerchant.com 
Level 17, Dashwood House 
 69 Old Broad Street, 
 London 
 EC2M 1QS 
 
 
   Note to Editors: 
 
   DXS International presents up to date treatment guidelines and 
recommendations, from Clinical Commissioning Groups and other trusted 
NHS sources, to doctors, nurses and pharmacists in their workflow and 
during the patient consultation. This effective clinical decision 
support ultimately translates to improved healthcare outcomes delivered 
more cost effectively which should significantly contribute towards the 
NHS achieving its projected efficiency savings. 
 
 
 
 

(END) Dow Jones Newswires

December 04, 2018 08:00 ET (13:00 GMT)